320 related articles for article (PubMed ID: 11297603)
1. Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia.
Maugeais C; Ouguerram K; Frénais R; Maugère P; Charbonnel B; Magot T; Krempf M
J Clin Endocrinol Metab; 2001 Apr; 86(4):1679-86. PubMed ID: 11297603
[TBL] [Abstract][Full Text] [Related]
2. Effects of weekly LDL-apheresis on metabolic parameters of apolipoprotein B in heterozygous familial hypercholesterolemia.
Parhofer KG; Barrett PH; Demant T; Richter WO; Schwandt P
J Lipid Res; 1996 Nov; 37(11):2383-93. PubMed ID: 8978490
[TBL] [Abstract][Full Text] [Related]
3. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100.
Zulewski H; Ninnis R; Miserez AR; Baumstark MW; Keller U
J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998
[TBL] [Abstract][Full Text] [Related]
4. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
[TBL] [Abstract][Full Text] [Related]
5. Low-density lipoprotein-apolipoprotein B metabolism following apheresis: simulation studies of mass changes and tracer kinetics.
Barrett PH; Parhofer KG
Metabolism; 1998 Apr; 47(4):478-83. PubMed ID: 9550549
[TBL] [Abstract][Full Text] [Related]
6. Lack of evidence for reduced plasma apo B48 catabolism in patients with heterozygous familial hypercholesterolemia carrying the same null LDL receptor gene mutation.
Tremblay AJ; Lamarche B; Ruel I; Hogue JC; Bergeron J; Gagné C; Couture P
Atherosclerosis; 2004 Feb; 172(2):367-73. PubMed ID: 15019548
[TBL] [Abstract][Full Text] [Related]
7. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
8. Effect of low-density lipoproteins on apolipoprotein AI kinetics in heterozygous familial hypercholesterolemia.
Frénais R; Maugeais C; Ouguerram K; Zaïr Y; Bard JM; Charbonnel B; Magot T; Krempf M
Metabolism; 2001 Jun; 50(6):635-9. PubMed ID: 11398137
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis.
Nenseter MS; Narverud I; Græsdal A; Bogsrud MP; Aukrust P; Retterstøl K; Ose L; Halvorsen B; Holven KB
J Clin Lipidol; 2013; 7(2):109-16. PubMed ID: 23415429
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of low density lipoprotein apheresis on metabolic parameters of apolipoprotein B.
Parhofer KG; Barrett PH; Demant T; Schwandt P
J Lipid Res; 2000 Oct; 41(10):1596-603. PubMed ID: 11013301
[TBL] [Abstract][Full Text] [Related]
11. Metabolic pathways of apolipoprotein B in heterozygous familial hypercholesterolemia: studies with a [3H]leucine tracer.
Fisher WR; Zech LA; Kilgore LL; Stacpoole PW
J Lipid Res; 1991 Nov; 32(11):1823-36. PubMed ID: 1770302
[TBL] [Abstract][Full Text] [Related]
12. Effects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia.
Tremblay AJ; Lamarche B; Ruel IL; Hogue JC; Deshaies Y; Gagné C; Couture P
Atherosclerosis; 2006 Sep; 188(1):203-12. PubMed ID: 16337207
[TBL] [Abstract][Full Text] [Related]
13. Nutritional regulation of cholesterol synthesis and apolipoprotein B kinetics: studies in patients with familial hypercholesterolemia and normal subjects treated with a high carbohydrate, low fat diet.
Stacpoole PW; von Bergmann K; Kilgore LL; Zech LA; Fisher WR
J Lipid Res; 1991 Nov; 32(11):1837-48. PubMed ID: 1770303
[TBL] [Abstract][Full Text] [Related]
14. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
[TBL] [Abstract][Full Text] [Related]
15. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
16. Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 production.
Millar JS; Maugeais C; Ikewaki K; Kolansky DM; Barrett PH; Budreck EC; Boston RC; Tada N; Mochizuki S; Defesche JC; Wilson JM; Rader DJ
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):560-5. PubMed ID: 15637307
[TBL] [Abstract][Full Text] [Related]
17. Effects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects.
Kearney T; de Gallegos CN; Proudler A; Parker K; Anayaoku V; Bannister P; Venkatesan S; Johnston DG
Metabolism; 2003 Jan; 52(1):50-9. PubMed ID: 12524662
[TBL] [Abstract][Full Text] [Related]
18. ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm.
Fisher WR; Zech LA; Stacpoole PW
Arterioscler Thromb; 1994 Apr; 14(4):501-10. PubMed ID: 8148348
[TBL] [Abstract][Full Text] [Related]
19. Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.
Teng B; Sniderman AD; Soutar AK; Thompson GR
J Clin Invest; 1986 Mar; 77(3):663-72. PubMed ID: 3949973
[TBL] [Abstract][Full Text] [Related]
20. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study.
Duvillard L; Pont F; Florentin E; Galland-Jos C; Gambert P; Vergès B
Eur J Clin Invest; 2000 Aug; 30(8):685-94. PubMed ID: 10964160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
